116 related articles for article (PubMed ID: 10617325)
1. Quantitative imaging of substance P in the human brain using a brain mapping analyzer.
Sutoo D; Yabe K; Akiyama K
Neurosci Res; 1999 Dec; 35(4):339-46. PubMed ID: 10617325
[TBL] [Abstract][Full Text] [Related]
2. Quantitative maps of GAbAergic and glutamatergic neuronal systems in the human brain.
Sutoo D; Akiyama K; Yabe K
Hum Brain Mapp; 2000 Oct; 11(2):93-103. PubMed ID: 11061336
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
4. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.
Reiner A; Medina L; Haber SN
Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817
[TBL] [Abstract][Full Text] [Related]
5. Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: a biochemical and immunohistochemical study.
Jessell TM; Emson PC; Paxinos G; Cuello AC
Brain Res; 1978 Sep; 152(3):487-98. PubMed ID: 356929
[TBL] [Abstract][Full Text] [Related]
6. Substance P and substance P receptor histochemistry in human neurodegenerative diseases.
Kowall NW; Quigley BJ; Krause JE; Lu F; Kosofsky BE; Ferrante RJ
Regul Pept; 1993 Jul; 46(1-2):174-85. PubMed ID: 7692486
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of differential substance P-, met-enkephalin-, and glutamic-acid-decarboxylase-containing cell body and axon distributions in the corpus striatum of the cat.
Beckstead RM; Kersey KS
J Comp Neurol; 1985 Feb; 232(4):481-98. PubMed ID: 2579980
[TBL] [Abstract][Full Text] [Related]
8. The distribution of substance P in the primate basal ganglia: an immunohistochemical study of baboon and human brain.
Beach TG; McGeer EG
Neuroscience; 1984 Sep; 13(1):29-52. PubMed ID: 6208509
[TBL] [Abstract][Full Text] [Related]
9. Quantitative imaging of tyrosine hydroxylase and calmodulin in the human brain.
Sutoo D; Akiyama K; Yabe K
J Neurosci Res; 2001 Mar; 63(5):369-76. PubMed ID: 11223911
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat.
Sugimoto T; Mizuno N
J Comp Neurol; 1987 Mar; 257(3):383-95. PubMed ID: 2435769
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of immunohistochemical distributions of cholinergic and catecholaminergic systems in the human brain.
Sutoo D; Akiyama K; Yabe K; Kohno K
Neuroscience; 1994 Jan; 58(1):227-34. PubMed ID: 7909146
[TBL] [Abstract][Full Text] [Related]
12. Striosomal organization of substance P-like immunoreactivity in parkinsonian patients.
Sakamoto S; Goto S; Ito H; Hirano A
Neurology; 1992 May; 42(5):1071-5. PubMed ID: 1374545
[TBL] [Abstract][Full Text] [Related]
13. A novel technique for quantitative immunohistochemical imaging of various neurochemicals in a multiple-stained brain slice.
Sutoo D; Akiyama K; Yabe K
J Neurosci Methods; 2002 Jul; 118(1):41-50. PubMed ID: 12191756
[TBL] [Abstract][Full Text] [Related]
14. Two new monoclonal antibodies provide immunohistochemical evidence for the unique biochemical similarity of the mouse globus pallidus, entopeduncular nucleus and substantia nigra pars reticulata.
Sousa R; Hrinya Tannery N; Lafer EM
Neuroscience; 1990; 34(2):403-10. PubMed ID: 2333150
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus.
Mesulam MM; Mash D; Hersh L; Bothwell M; Geula C
J Comp Neurol; 1992 Sep; 323(2):252-68. PubMed ID: 1401259
[TBL] [Abstract][Full Text] [Related]
17. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions.
Marksteiner J; Saria A; Kirchmair R; Pycha R; Benesch H; Fischer-Colbrie R; Haring C; Maier H; Ransmayr G
Eur J Neurosci; 1993 Dec; 5(12):1573-85. PubMed ID: 7510203
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra.
Haber SN; Groenewegen HJ
J Comp Neurol; 1989 Dec; 290(1):53-68. PubMed ID: 2480370
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.
Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP
Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain.
Castel MN; Morino P; Frey P; Terenius L; Hökfelt T
Neuroscience; 1993 Aug; 55(3):833-47. PubMed ID: 8105419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
